UK Weeks Away From Medicine Shortages as Iran War Disrupts Global Supply Chains
Experts warn painkillers to cancer treatments could run short as conflict cuts off crucial raw materials
The warning comes as the Iran conflict enters its third week with no sign of a ceasefire. Iran is a significant producer of raw materials used in pharmaceutical manufacturing, and the disruption to shipping through the Strait of Hormuz has compounded the problem by delaying deliveries from other suppliers.
Drug prices are already rising as manufacturers scramble to secure alternative sources. The NHS, already under enormous pressure from strikes and funding constraints, faces the prospect of rationing certain medications if shortages materialise.
The situation echoes the supply chain chaos of the early COVID pandemic, when global pharmaceutical supply lines proved far more fragile than anyone expected. Unlike COVID, however, the current disruption has a clear geopolitical cause with no predictable end date.
Analysis
Why This Matters
Medicine shortages hit the most vulnerable first: cancer patients, people with chronic conditions, and those dependent on specific formulations. The UK imports a significant proportion of its pharmaceutical raw materials, making it particularly exposed.
Background
The Strait of Hormuz handles roughly 20 per cent of global oil supply and is a critical shipping route for many other goods. Iran's threat to permanently toll or block the strait has sent shockwaves through global supply chains far beyond energy markets.
Key Perspectives
Pharmaceutical industry groups are urging the government to activate emergency stockpiles and fast-track regulatory approvals for alternative suppliers. The NHS is reportedly drawing up contingency plans for medication rationing.
What to Watch
Whether the government releases strategic pharmaceutical reserves and how quickly alternative supply routes can be established.